Literature DB >> 12590661

Penetration of human skin by the cercariae of Schistosoma mansoni: an investigation of the effect of multiple cercarial applications.

R J Ingram1, A Bartlett, M B Brown, C Marriott, P J Whitfield.   

Abstract

It has previously been postulated that L-arginine emitted by penetrating Schistosoma mansoni cercariae serves as an intraspecific signal guiding other cercariae to the penetration site. It was suggested that penetrating in groups offers a selective advantage. If this hypothesis is correct and group penetration at one site on the host offers an advantage, it would follow that at such a site, successive groups of cercariae would be able to penetrate skin in either greater numbers or at a faster rate. This prediction was tested by the use of an in vitro model of cercarial penetration based on the Franz cell and using human skin. It was demonstrated that there was no increase in the percentage of cercariae able to penetrate the skin with subsequent exposures. Consequently, it seems unlikely that the release of L-arginine by cercariae during penetration could have evolved as a specific orientation system based on a selective advantage offered by group penetration.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12590661     DOI: 10.1079/JOH2002157

Source DB:  PubMed          Journal:  J Helminthol        ISSN: 0022-149X            Impact factor:   2.170


  2 in total

1.  Determination of the Permeation and Penetration of Flurbiprofen into Cadaveric Human Pharynx Tissue.

Authors:  Rob Turner; Sean Robert Wevrett; Suzanne Edmunds; Marc B Brown; Robert Atkinson; Oluwajoba Adegoke; Anuradha Kulasekaran; Tim Shea
Journal:  Clin Pharmacol       Date:  2020-03-24

2.  Validation of an analytical method to quantify the permeation and penetration of flurbiprofen into human pharynx tissue.

Authors:  Rob Turner; Sean Robert Wevrett; Suzanne Edmunds; Marc Brown; Robert Atkinson; Tim Shea
Journal:  Biomed Chromatogr       Date:  2019-05-06       Impact factor: 1.902

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.